BioXcel Therapeutics Inc
BTAI
$0.05+19.22%
End of day · as of Sep 30, 2026, 2:31 AM ET
Mkt cap
$36.13M
EV/Sales
182.7
P/E ratio
N/A
FY2025 Revenue
$642,000
EPS (TTM)
$-5.77
Gross Margin (FY2025)
74.45%
Profit Margin (FY2025)
-10887.38%
Beta
0.31
Div yield
N/A
Sector
Healthcare
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BTAI revenue for 2025-12-31 was $642.0K. Net income was -$69.9M. Revenue was down 71.7% from 2024-12-31 to 2025-12-31. BTAI currently screens at market cap $36.1M.
Use this BTAI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BTAI income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached BioXcel Therapeutics Inc (BTAI) revenue for Dec 31, 2025 was $642.0K. Net income was -$69.9M. Statements: https://lician.com/financials/btai
BioXcel Therapeutics Inc (BTAI) market capitalization is $36.1M on the latest cached snapshot.
BioXcel Therapeutics Inc (BTAI) cached previous close $0.04; day range $0.03 – $0.05; volume 1,047,987. Session quote: https://lician.com/quote/btai
BioXcel Therapeutics Inc (BTAI) latest cached earnings event is "BTAI earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BTAI filing is 8-K · Sep 1, 2026. Filings: https://lician.com/sec/btai